Article Listing - US FDA advisory panel split on keeping Abbott’s obesity drug Meridia on the market

BOOTS TO COPROMOTE W-L'S LOPID

10 February 1992

Boots Co has announced that its wholly-owned US subsidiary, Boots Pharmaceuticals Inc, has commenced the copromotion of Warner-Lambert subsidiary Parke-Davis'...

W-L CANADA PROMOTION

10 February 1992

Robert Clouston becomes president and general manager, consumer products, at Warner-Lambert Canada Inc.

AEROBEC AUTOHALER EXTENSION

10 February 1992

3M Health Care's breath- actuated AeroBec Autohaler range in the UK, containing beclomethasone dipropionate, has now been extended to include...

VANGUARD MEDICA SEEKING OUT NDCs

10 February 1992

A new pharmaceutical company has been formed in the UK to develop innovative new drugs which, for reasons unassociated with...

CELLTECH HALVES LOSSES IN FISCAL 1991

10 February 1992

The Celltech Group, which claims to be the largest independent biotechnology company in the UK, announced that it has halved...

AUSTRALIAN Ab KIT DEVELOPMENT BOOST

10 February 1992

A boost to the research into the development and use of antibody-based test kits has been made in Australia with...

US FDA TAKING LONGER TO APPROVE NEW DRUGS

10 February 1992

The US Food and Drug Administra-tion is taking longer to review new drugs, and in 1991 required an average of...

STOCK MARKET COMMENTARY: NEW YORK

10 February 1992

NEW YORK: had no time to respond to President George Bush's State of the Union message before Federal Bank chief...

STOCK MARKET COMMENTARY: TOKYO

10 February 1992

TOKYO: recovered to the 22,000 yen level for the first time since January 10, in continued low volume. But on...

STOCK MARKET COMMENTARY: EUROPE

10 February 1992

EUROPE: saw most stock markets down by the end of the reporting period, with FRANKFURT doing marg-inally better. Among the...

Showing 94841-94850 of 95353 articles